Status: Awaiting development Technology type: Medicine Decision: Selected Reason for decision: Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the ...

Somapacitan for treating growth failure caused by Turner syndrome in people 2 to 17 years [TSID12226] Awaiting development GID-TA11821 Expected publication date: TBC ...

Status: Awaiting development Technology type: Medicine Decision: Selected Reason for decision: Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the ...

Tarlatamamb for treating small-cell lung cancer that has progressed after platinum-based chemotherapy [ID6617] Awaiting development GID-TA11812 Expected publication date: TBC ...

NICE has recommended a new first-line treatment for adults with advanced bladder cancer, marking a significant breakthrough for patients facing this devastating disease.

Serplulimab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer [ID6346] In development GID-TA11405 Expected publication date: TBC ...

3 Committee discussion The advisory committee considered evidence from several sources on transcatheter heart valves for transcatheter aortic valve implantation (TAVI) in people with aortic stenosis.

Ten transcatheter heart valves were available on the NHS Supply Chain and included in this assessment at the time of publication. All of them had valid CE certification as class 3 implantable devices.

There is not enough evidence to determine whether price variation is justified between different transcatheter heart valves for transcatheter aortic valve implantation (TAVI) in adults with aortic ...